chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung.
Regulators have set a goal of Aug. 12, 2025, for brensocatib to treat patients with non-cystic fibrosis bronchiectasis, a chronic lung disease. The FDA has accepted Insmed’s new drug application for ...
In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples, that can be obtained from a cheek swab or blood test, they can improve identification of people ...